HIVNCT07528573
HIV Prevention and Care Engagement in Nepal
A study testing Sweekar intervention in people with HIV, run by Public Health Foundation Enterprises, Inc. at 1 site in Nepal.
Trial summary
This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma. Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- HIV
- What is being tested?
- Sweekar intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteNepal
- Study dates
- 27 May 2024to 31 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- aged 18 years old or older
- identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
- live in the Terai highway district Madesh Province
- Maithili- or Nepali-speaking
- Willing to be part of the study for 6 months
- Willing to travel, if needed, to participate in group sessions
Show all 12Show fewer
- For those who test HIV negative:
- Willing to self-test
- Have or willing to have a mobile phone
- Not HIV tested within the last 3 months
- For those who test HIV positive:
- screen positive for HIV treatment non-adherence by self-report
Who cannot join
- Cannot or will not consent to the research,
- Female sex assigned at birth,
- Self-identify as a man
- Do not speak Maithli or Nepali
- Age under 18 -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal
This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma. Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs.
- Conditions
- HIV
- Being tested
- Sweekar intervention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sweekar interventionBehavioural
The HIV prevention components focus on HIV education and use of HIV self-testing kits to increase frequency of HIV testing. The HIV care component is information and linkage to HIV treatment information and adherence support.
| Study group | Role | What they receive |
|---|---|---|
| Group-based intervention | Experimental | Group-based activities and HIV self-testing to address social stigma and HIV prevention and care needs Receives: Behavioral: Sweekar intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
HIV testing Self-testing kits
Number of HIV self tests kits used at home or at a hospital or clinic
Measured: At baseline and at 3 months
HIV testing frequency
HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits
Measured: Baseline, 3 months and 6 months
HIV treatment engagement
Self-reported Wilson's Medication Scale to assess adherence patterns.
Measured: At baseline, 3 months and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2026
- Study start27 May 2024
- Primary completion31 May 2025
- Study completion31 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIVStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Public Health Foundation Enterprises, Inc.
- Sponsor type
- University, hospital or other
- Collaborators
- Fogarty International Center of the National Institute of Health
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07528573
- Sponsor's protocol ID
- 4632024
- Other IDs
- R01TW012397
- Status last verified
- Apr 2026
- First submitted
- 27 Oct 2025
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Upon request, data may be made available
Study at a glance
From the registry record, last updated by the sponsor on 14 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal
- ClinicalTrials.gov ID
- NCT07528573
- Acronym / sponsor ID
- 4632024
- Conditions
- HIV
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Public Health Foundation Enterprises, Inc.University, hospital or other
- Collaborators
- Fogarty International Center of the National Institute of Health
- Study start
- 27 May 2024 (actual)
- Primary completion
- 31 May 2025 (actual)
- Study completion
- 31 May 2025 (actual)
- First posted
- 14 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma. Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group-based intervention | Experimental | Behavioral: Sweekar interventionGroup-based activities and HIV self-testing to address social stigma and HIV prevention and care needs |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (12 listed)
- aged 18 years old or older
- identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
- live in the Terai highway district Madesh Province
- Maithili- or Nepali-speaking
- Willing to be part of the study for 6 months
Key exclusion criteria (5 listed)
- Cannot or will not consent to the research,
- Female sex assigned at birth,
- Self-identify as a man
- Do not speak Maithli or Nepali
- Age under 18 -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sweekar interventionThe HIV prevention components focus on HIV education and use of HIV self-testing kits to increase frequency of HIV testing. The HIV care component is information and linkage to HIV treatment information and adherence support. | Behavioural | Group-based intervention |
Primary outcome
HIV testing Self-testing kits
Time frame: At baseline and at 3 months
Number of HIV self tests kits used at home or at a hospital or clinic
HIV testing frequency
Time frame: Baseline, 3 months and 6 months
HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits
HIV treatment engagement
Time frame: At baseline, 3 months and 6 months
Self-reported Wilson's Medication Scale to assess adherence patterns.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Apr 2026.
- Individual participant dataSharing planned: Undecided. Upon request, data may be made available
Related trials for HIV
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sweekar intervention in people with HIV, run by Public Health Foundation Enterprises, Inc. at 1 site in Nepal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Nepal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HIV testing Self-testing kits (time frame: At baseline and at 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.